Monopar Therapeutics
MNPRNasdaqCIK 1645469HealthcareFiscal year ends Dec 31
Income statement
| Line item | Unit | Q3 FY20232023-09-30 | Q4 FY20232023-12-31 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | Q4 FY20242024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | Q4 FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | 0.0Revenue, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-14, accession 0001437749-26-016982.Report this figure | 0.0Revenue, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-12, accession 0001437749-26-027164. Derived: 6-month figure less the 3-month figure.Report this figure |
| Research and development | $m | 1.3Research and development, Q3 FY2023, three months to 2023-09-30$1.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-08, accession 0001437749-24-034048.Report this figure | 1.0Research and development, Q4 FY2023, three months to 2023-12-31$1.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-31, accession 0001437749-25-009979. Derived: 12-month figure less the 9-month figure.Report this figure | 1.0Research and development, Q1 FY2024, three months to 2024-03-31$966.1k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-13, accession 0001437749-25-016263.Report this figure | 1.1Research and development, Q2 FY2024, three months to 2024-06-30$1.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0001437749-25-026042.Report this figure | 1.0Research and development, Q3 FY2024, three months to 2024-09-30$984.3k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001437749-25-034617.Report this figure | 9.9Research and development, Q4 FY2024, three months to 2024-12-31$9.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-27, accession 0001437749-26-010025. Derived: 12-month figure less the 9-month figure.Report this figure | 1.6Research and development, Q1 FY2025, three months to 2025-03-31$1.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001437749-26-016982.Report this figure | 1.7Research and development, Q2 FY2025, three months to 2025-06-30$1.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001437749-26-027164.Report this figure | 2.6Research and development, Q3 FY2025, three months to 2025-09-30$2.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001437749-25-034617.Report this figure | 3.9Research and development, Q4 FY2025, three months to 2025-12-31$3.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-27, accession 0001437749-26-010025. Derived: 12-month figure less the 9-month figure.Report this figure | 3.5Research and development, Q1 FY2026, three months to 2026-03-31$3.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001437749-26-016982.Report this figure | 4.8Research and development, Q2 FY2026, three months to 2026-06-30$4.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001437749-26-027164.Report this figure |
| Operating income | $m | (2.1)Operating income, Q3 FY2023, three months to 2023-09-30−$2.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-08, accession 0001437749-24-034048.Report this figure | (1.9)Operating income, Q4 FY2023, three months to 2023-12-31−$1.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-31, accession 0001437749-25-009979. Derived: 12-month figure less the 9-month figure.Report this figure | (1.7)Operating income, Q1 FY2024, three months to 2024-03-31−$1.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-13, accession 0001437749-25-016263.Report this figure | (1.8)Operating income, Q2 FY2024, three months to 2024-06-30−$1.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0001437749-25-026042.Report this figure | (1.6)Operating income, Q3 FY2024, three months to 2024-09-30−$1.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001437749-25-034617.Report this figure | (11.1)Operating income, Q4 FY2024, three months to 2024-12-31−$11.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-27, accession 0001437749-26-010025. Derived: 12-month figure less the 9-month figure.Report this figure | (3.2)Operating income, Q1 FY2025, three months to 2025-03-31−$3.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001437749-26-016982.Report this figure | (3.2)Operating income, Q2 FY2025, three months to 2025-06-30−$3.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001437749-26-027164.Report this figure | (4.1)Operating income, Q3 FY2025, three months to 2025-09-30−$4.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001437749-25-034617.Report this figure | (6.2)Operating income, Q4 FY2025, three months to 2025-12-31−$6.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-27, accession 0001437749-26-010025. Derived: 12-month figure less the 9-month figure.Report this figure | (5.2)Operating income, Q1 FY2026, three months to 2026-03-31−$5.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001437749-26-016982.Report this figure | (6.6)Operating income, Q2 FY2026, three months to 2026-06-30−$6.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001437749-26-027164.Report this figure |
| Net income | $m | (2.0)Net income, Q3 FY2023, three months to 2023-09-30−$2.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-08, accession 0001437749-24-034048.Report this figure | (1.8)Net income, Q4 FY2023, three months to 2023-12-31−$1.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-31, accession 0001437749-25-009979. Derived: 12-month figure less the 9-month figure.Report this figure | (1.6)Net income, Q1 FY2024, three months to 2024-03-31−$1.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001437749-25-034617.Report this figure | (1.7)Net income, Q2 FY2024, three months to 2024-06-30−$1.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001437749-25-034617.Report this figure | (1.3)Net income, Q3 FY2024, three months to 2024-09-30−$1.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001437749-25-034617.Report this figure | (10.9)Net income, Q4 FY2024, three months to 2024-12-31−$10.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-27, accession 0001437749-26-010025. Derived: 12-month figure less the 9-month figure.Report this figure | (2.6)Net income, Q1 FY2025, three months to 2025-03-31−$2.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001437749-26-027164.Report this figure | (2.5)Net income, Q2 FY2025, three months to 2025-06-30−$2.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001437749-26-027164.Report this figure | (3.4)Net income, Q3 FY2025, three months to 2025-09-30−$3.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001437749-25-034617.Report this figure | (5.2)Net income, Q4 FY2025, three months to 2025-12-31−$5.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-27, accession 0001437749-26-010025. Derived: 12-month figure less the 9-month figure.Report this figure | (3.9)Net income, Q1 FY2026, three months to 2026-03-31−$3.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001437749-26-027164.Report this figure | (5.3)Net income, Q2 FY2026, three months to 2026-06-30−$5.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001437749-26-027164.Report this figure |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | (0.69)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.69 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-08, accession 0001437749-24-034048.Report this figure | not reported | (0.51)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.51 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-13, accession 0001437749-25-016263.Report this figure | (0.49)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.49 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-12, accession 0001437749-25-026042.Report this figure | (0.37)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.37 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001437749-25-034617.Report this figure | not reported | (0.38)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.38 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001437749-26-016982.Report this figure | (0.35)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.35 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001437749-26-027164.Report this figure | (0.48)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.48 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001437749-25-034617.Report this figure | not reported | (0.46)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.46 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001437749-26-016982.Report this figure | (0.62)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.62 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001437749-26-027164.Report this figure |
Balance sheet
| Line item | Unit | Q3 FY20232023-09-30 | FY20232023-12-31 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | FY20242024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $m | 5.5Cash and equivalents, Q3 FY2023, at 2023-09-30$5.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-09, accession 0001437749-23-031066.Report this figure | 7.3Cash and equivalents, FY2023, at 2023-12-31$7.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-31, accession 0001437749-25-009979.Report this figure | 7.8Cash and equivalents, Q1 FY2024, at 2024-03-31$7.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-09, accession 0001437749-24-015454.Report this figure | 6.1Cash and equivalents, Q2 FY2024, at 2024-06-30$6.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-09, accession 0001437749-24-025651.Report this figure | 6.0Cash and equivalents, Q3 FY2024, at 2024-09-30$6.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-08, accession 0001437749-24-034048.Report this figure | 45.8Cash and equivalents, FY2024, at 2024-12-31$45.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-27, accession 0001437749-26-010025.Report this figure | 39.7Cash and equivalents, Q1 FY2025, at 2025-03-31$39.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-13, accession 0001437749-25-016263.Report this figure | 39.5Cash and equivalents, Q2 FY2025, at 2025-06-30$39.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-12, accession 0001437749-25-026042.Report this figure | 128Cash and equivalents, Q3 FY2025, at 2025-09-30$127.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001437749-25-034617.Report this figure | 61.8Cash and equivalents, FY2025, at 2025-12-31$61.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001437749-26-027164.Report this figure | 52.5Cash and equivalents, Q1 FY2026, at 2026-03-31$52.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-14, accession 0001437749-26-016982.Report this figure | 52.8Cash and equivalents, Q2 FY2026, at 2026-06-30$52.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001437749-26-027164.Report this figure |
| Current assets | $m | 8.6Current assets, Q3 FY2023, at 2023-09-30$8.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0001437749-23-031066.Report this figure | 7.3Current assets, FY2023, at 2023-12-31$7.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-31, accession 0001437749-25-009979.Report this figure | 8.9Current assets, Q1 FY2024, at 2024-03-31$8.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0001437749-24-015454.Report this figure | 7.2Current assets, Q2 FY2024, at 2024-06-30$7.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-09, accession 0001437749-24-025651.Report this figure | 6.1Current assets, Q3 FY2024, at 2024-09-30$6.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-08, accession 0001437749-24-034048.Report this figure | 60.3Current assets, FY2024, at 2024-12-31$60.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-27, accession 0001437749-26-010025.Report this figure | 55.1Current assets, Q1 FY2025, at 2025-03-31$55.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-13, accession 0001437749-25-016263.Report this figure | 53.7Current assets, Q2 FY2025, at 2025-06-30$53.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-12, accession 0001437749-25-026042.Report this figure | 144Current assets, Q3 FY2025, at 2025-09-30$144.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-13, accession 0001437749-25-034617.Report this figure | 140Current assets, FY2025, at 2025-12-31$140.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001437749-26-027164.Report this figure | 138Current assets, Q1 FY2026, at 2026-03-31$137.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-14, accession 0001437749-26-016982.Report this figure | 135Current assets, Q2 FY2026, at 2026-06-30$134.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001437749-26-027164.Report this figure |
| Total assets | $m | 8.6Total assets, Q3 FY2023, at 2023-09-30$8.6m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0001437749-23-031066.Report this figure | 7.3Total assets, FY2023, at 2023-12-31$7.3m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-31, accession 0001437749-25-009979.Report this figure | 8.9Total assets, Q1 FY2024, at 2024-03-31$8.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0001437749-24-015454.Report this figure | 7.2Total assets, Q2 FY2024, at 2024-06-30$7.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-09, accession 0001437749-24-025651.Report this figure | 6.1Total assets, Q3 FY2024, at 2024-09-30$6.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-08, accession 0001437749-24-034048.Report this figure | 60.3Total assets, FY2024, at 2024-12-31$60.3m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-27, accession 0001437749-26-010025.Report this figure | 55.1Total assets, Q1 FY2025, at 2025-03-31$55.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-13, accession 0001437749-25-016263.Report this figure | 53.9Total assets, Q2 FY2025, at 2025-06-30$53.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0001437749-25-026042.Report this figure | 144Total assets, Q3 FY2025, at 2025-09-30$144.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-13, accession 0001437749-25-034617.Report this figure | 141Total assets, FY2025, at 2025-12-31$140.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001437749-26-027164.Report this figure | 138Total assets, Q1 FY2026, at 2026-03-31$138.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-14, accession 0001437749-26-016982.Report this figure | 135Total assets, Q2 FY2026, at 2026-06-30$135.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001437749-26-027164.Report this figure |
| Current liabilities | $m | 2.0Current liabilities, Q3 FY2023, at 2023-09-30$2.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0001437749-23-031066.Report this figure | 1.8Current liabilities, FY2023, at 2023-12-31$1.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2024-03-28, accession 0001437749-24-009687.Report this figure | not reported | not reported | not reported | 5.3Current liabilities, FY2024, at 2024-12-31$5.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-27, accession 0001437749-26-010025.Report this figure | not reported | 1.6Current liabilities, Q2 FY2025, at 2025-06-30$1.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-12, accession 0001437749-25-026042.Report this figure | 2.6Current liabilities, Q3 FY2025, at 2025-09-30$2.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-13, accession 0001437749-25-034617.Report this figure | 2.7Current liabilities, FY2025, at 2025-12-31$2.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001437749-26-027164.Report this figure | 2.5Current liabilities, Q1 FY2026, at 2026-03-31$2.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-14, accession 0001437749-26-016982.Report this figure | 4.0Current liabilities, Q2 FY2026, at 2026-06-30$4.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001437749-26-027164.Report this figure |
| Total liabilities | $m | 2.0Total liabilities, Q3 FY2023, at 2023-09-30$2.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0001437749-23-031066.Report this figure | 1.8Total liabilities, FY2023, at 2023-12-31$1.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-31, accession 0001437749-25-009979.Report this figure | 1.4Total liabilities, Q1 FY2024, at 2024-03-31$1.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0001437749-24-015454.Report this figure | 1.1Total liabilities, Q2 FY2024, at 2024-06-30$1.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-09, accession 0001437749-24-025651.Report this figure | 1.1Total liabilities, Q3 FY2024, at 2024-09-30$1.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-08, accession 0001437749-24-034048.Report this figure | 5.3Total liabilities, FY2024, at 2024-12-31$5.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-27, accession 0001437749-26-010025.Report this figure | 1.5Total liabilities, Q1 FY2025, at 2025-03-31$1.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-13, accession 0001437749-25-016263.Report this figure | 1.7Total liabilities, Q2 FY2025, at 2025-06-30$1.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-12, accession 0001437749-25-026042.Report this figure | 2.6Total liabilities, Q3 FY2025, at 2025-09-30$2.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-13, accession 0001437749-25-034617.Report this figure | 2.9Total liabilities, FY2025, at 2025-12-31$2.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001437749-26-027164.Report this figure | 2.6Total liabilities, Q1 FY2026, at 2026-03-31$2.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-14, accession 0001437749-26-016982.Report this figure | 4.1Total liabilities, Q2 FY2026, at 2026-06-30$4.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001437749-26-027164.Report this figure |
| Shareholders' equity | $m | 6.6Shareholders' equity, Q3 FY2023, at 2023-09-30$6.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-08, accession 0001437749-24-034048.Report this figure | 5.6Shareholders' equity, FY2023, at 2023-12-31$5.6m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-27, accession 0001437749-26-010025.Report this figure | 7.5Shareholders' equity, Q1 FY2024, at 2024-03-31$7.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001437749-25-034617.Report this figure | 6.1Shareholders' equity, Q2 FY2024, at 2024-06-30$6.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001437749-25-034617.Report this figure | 4.9Shareholders' equity, Q3 FY2024, at 2024-09-30$4.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001437749-25-034617.Report this figure | 55.0Shareholders' equity, FY2024, at 2024-12-31$55.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001437749-26-027164.Report this figure | 53.6Shareholders' equity, Q1 FY2025, at 2025-03-31$53.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001437749-26-027164.Report this figure | 52.2Shareholders' equity, Q2 FY2025, at 2025-06-30$52.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001437749-26-027164.Report this figure | 142Shareholders' equity, Q3 FY2025, at 2025-09-30$141.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001437749-25-034617.Report this figure | 138Shareholders' equity, FY2025, at 2025-12-31$137.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001437749-26-027164.Report this figure | 135Shareholders' equity, Q1 FY2026, at 2026-03-31$135.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001437749-26-027164.Report this figure | 131Shareholders' equity, Q2 FY2026, at 2026-06-30$130.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001437749-26-027164.Report this figure |
Cash flow
| Line item | Unit | Q3 FY20232023-09-30 | Q4 FY20232023-12-31 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | Q4 FY20242024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | Q4 FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $k | (1,940)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$1.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-08, accession 0001437749-24-034048. Derived: 9-month figure less the 6-month figure.Report this figure | (1,546)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$1.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-31, accession 0001437749-25-009979. Derived: 12-month figure less the 9-month figure.Report this figure | (1,655)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$1.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-13, accession 0001437749-25-016263.Report this figure | (1,677)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$1.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0001437749-25-026042. Derived: 6-month figure less the 3-month figure.Report this figure | (1,074)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$1.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001437749-25-034617. Derived: 9-month figure less the 6-month figure.Report this figure | (1,998)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$2.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-27, accession 0001437749-26-010025. Derived: 12-month figure less the 9-month figure.Report this figure | (5,663)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$5.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001437749-26-016982.Report this figure | (1,077)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$1.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001437749-26-027164. Derived: 6-month figure less the 3-month figure.Report this figure | (2,091)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$2.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001437749-25-034617. Derived: 9-month figure less the 6-month figure.Report this figure | (3,370)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$3.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-27, accession 0001437749-26-010025. Derived: 12-month figure less the 9-month figure.Report this figure | (3,474)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$3.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001437749-26-016982.Report this figure | (3,247)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$3.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001437749-26-027164. Derived: 6-month figure less the 3-month figure.Report this figure |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | 0.0Share repurchases, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-03-27, accession 0001437749-26-010025. Derived: 12-month figure less the 9-month figure.Report this figure | not reported | not reported | not reported | 0.0Share repurchases, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-03-27, accession 0001437749-26-010025. Derived: 12-month figure less the 9-month figure.Report this figure | not reported | not reported |
Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. Listed shows no prices and gives no investment advice.